Valeant Pharmaceuticals earnings

Valeant And Pershing May Sweeten Allergan Deal By $15 A Share

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) and Bill Ackman’s Pershing Square are said to be planning to boost their offer to acquire Botox maker Allergan, Inc. (NYSE:AGN) by $15 a share, according to people familiar with the developments.

The enhanced offer marks Valeant and Pershing Square’s third increase to their original bid.
Valeant - Allergan merger could be the largest deal of the year
The latest bid from Valeant Pharmaceuticals and Pershing is intended to keep the Botox maker . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code 2019VIP or click on the button below

Limited time offer only ENDS TONIGHT or next 20 5 subscribers whichever comes first – please do not share this discount with others